Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Drug Metabolism and Pharmacokinetics
|
July 13, 2012
Population pharmacokinetic-pharmacodynamic modeling and simulation of platelet decrease induced by peg-interferon-alpha 2a
Tomohisa Saito, Satofumi Iida, Takehiko Kawanishi
Journal of Clinical Pharmacology
|
July 14, 2017
Dosage Optimization of Nemolizumab Using Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling and Simulation
Tomohisa Saito, Satofumi Iida, Kimio Terao, et al.
Biopharmaceutics & Drug Disposition
|
June 16, 2010
Prediction of human blood-to-plasma drug concentration ratio
Takahide Uchimura, Motohiro Kato, Tomohisa Saito, et al.
Expert Review of Clinical Pharmacology
|
March 12, 2013
Clinical pharmacology of tocilizumab for the treatment of systemic juvenile idiopathic arthritis
Xiaoping Zhang, Peter N Morcos, Tomohisa Saito, et al.
The Journal of Pharmacy and Pharmacology
|
July 11, 2013
Population pharmacokinetic-pharmacodynamic modelling and simulation of neutropenia induced by TP300, a novel topoisomerase I inhibitor
Tomohisa Saito, Satofumi Iida, Masaichi Abe, et al.
Biological & Pharmaceutical Bulletin
|
August 5, 2009
A simulation study to evaluate limited sampling strategies to estimate area under the curve of drug concentration versus time following repetitive oral dosing: limited sampling model versus naive trapezoidal method
Yuichiro Kayano, Isao Horiuchi, Yun-i Mori, et al.
Drug Research
|
August 14, 2018
Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Tofogliflozin (A SELECTIVE SGLT2 Inhibitor) in Patients with Type 2 Diabetes Mellitus
Sachiya Ikeda, Yasuki Takano, Dietmar Schwab, et al.
Clinical Pharmacokinetics
|
December 31, 2015
Combining 'Bottom-Up' and 'Top-Down' Methods to Assess Ethnic Difference in Clearance: Bitopertin as an Example
Sheng Feng, Jun Shi, Neil Parrott, et al.
Drug Research
|
September 6, 2021
Maxacalcitol Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Secondary Hyperparathyroidism in Patients Receiving Maintenance Hemodialysis
Mizuki Fukazawa-Shinotsuka, Tomohisa Saito, Masaichi Abe, et al.
Journal of the American Chemical Society
|
July 11, 2008
Reversible mechanochromic luminescence of [(C6F5Au)2(mu-1,4-diisocyanobenzene)]
Hajime Ito, Tomohisa Saito, Naoya Oshima, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Drug Metabolism and Pharmacokinetics
|
July 13, 2012
Population pharmacokinetic-pharmacodynamic modeling and simulation of platelet decrease induced by peg-interferon-alpha 2a
Tomohisa Saito, Satofumi Iida, Takehiko Kawanishi
Journal of Clinical Pharmacology
|
July 14, 2017
Dosage Optimization of Nemolizumab Using Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling and Simulation
Tomohisa Saito, Satofumi Iida, Kimio Terao, et al.
Biopharmaceutics & Drug Disposition
|
June 16, 2010
Prediction of human blood-to-plasma drug concentration ratio
Takahide Uchimura, Motohiro Kato, Tomohisa Saito, et al.
Expert Review of Clinical Pharmacology
|
March 12, 2013
Clinical pharmacology of tocilizumab for the treatment of systemic juvenile idiopathic arthritis
Xiaoping Zhang, Peter N Morcos, Tomohisa Saito, et al.
The Journal of Pharmacy and Pharmacology
|
July 11, 2013
Population pharmacokinetic-pharmacodynamic modelling and simulation of neutropenia induced by TP300, a novel topoisomerase I inhibitor
Tomohisa Saito, Satofumi Iida, Masaichi Abe, et al.
Biological & Pharmaceutical Bulletin
|
August 5, 2009
A simulation study to evaluate limited sampling strategies to estimate area under the curve of drug concentration versus time following repetitive oral dosing: limited sampling model versus naive trapezoidal method
Yuichiro Kayano, Isao Horiuchi, Yun-i Mori, et al.
Drug Research
|
August 14, 2018
Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Tofogliflozin (A SELECTIVE SGLT2 Inhibitor) in Patients with Type 2 Diabetes Mellitus
Sachiya Ikeda, Yasuki Takano, Dietmar Schwab, et al.
Clinical Pharmacokinetics
|
December 31, 2015
Combining 'Bottom-Up' and 'Top-Down' Methods to Assess Ethnic Difference in Clearance: Bitopertin as an Example
Sheng Feng, Jun Shi, Neil Parrott, et al.
Drug Research
|
September 6, 2021
Maxacalcitol Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Secondary Hyperparathyroidism in Patients Receiving Maintenance Hemodialysis
Mizuki Fukazawa-Shinotsuka, Tomohisa Saito, Masaichi Abe, et al.
Journal of the American Chemical Society
|
July 11, 2008
Reversible mechanochromic luminescence of [(C6F5Au)2(mu-1,4-diisocyanobenzene)]
Hajime Ito, Tomohisa Saito, Naoya Oshima, et al.
Page
of 3